These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6372175)

  • 21. The 2nd NIEHS Predictive-Toxicology Evaluation Experiment: 30 chemical carcinogenicity bioassays.
    Environ Health Perspect; 1996 Oct; 104 Suppl 5():999-1112. PubMed ID: 9036020
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of non-mammalian species in bioassays for carcinogenicity.
    Bunton TE
    IARC Sci Publ; 1999; (146):151-84. PubMed ID: 10353387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of animal carcinogenicity studies for goodness-of-fit of multistage models.
    Portier CJ; Hoel DG
    Fundam Appl Toxicol; 1984 Dec; 4(6):949-59. PubMed ID: 6519375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of data from short-term tests in the evaluation of the carcinogenicity of environmental chemicals to humans.
    Yamasaki H; Wilbourn JD; Haroun L
    Prog Clin Biol Res; 1982; 109():169-80. PubMed ID: 7167540
    [No Abstract]   [Full Text] [Related]  

  • 26. Cooperative programme on long-term assays for carcinogenicity in Japan.
    Odashima S
    IARC Sci Publ; 1980; (27):315-22. PubMed ID: 7439964
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of the threshold concept in teratogenicity studies.
    Giavini E
    Teratology; 1988 Oct; 38(4):393-5. PubMed ID: 3238596
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical carcinogens and human risk assessment.
    Campbell TC
    Fed Proc; 1980 Jun; 39(8):2467-84. PubMed ID: 6991290
    [No Abstract]   [Full Text] [Related]  

  • 29. The threshold dose question in teratogenesis.
    Gaylor DW; Sheehan DM; Young JF; Mattison DR
    Teratology; 1988 Oct; 38(4):389-91. PubMed ID: 3238595
    [No Abstract]   [Full Text] [Related]  

  • 30. Carcinogen testing & public information.
    Upton AC
    Hastings Cent Rep; 1980 Feb; 10(1):9-10. PubMed ID: 7372460
    [No Abstract]   [Full Text] [Related]  

  • 31. The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.
    Venditti JM
    Cancer Treat Rep; 1983 Sep; 67(9):767-72. PubMed ID: 6883352
    [No Abstract]   [Full Text] [Related]  

  • 32. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):83-96. PubMed ID: 16386343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospects of short-term tests in primary cancer prevention.
    Khudoley VV; Pliss GB
    Neoplasma; 1984; 31(4):475-8. PubMed ID: 6472519
    [No Abstract]   [Full Text] [Related]  

  • 34. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to "Use of Statistics when Examining Lifetime Studies in Rodents to Detect Carcinogenicity".
    Haseman JK
    J Toxicol Environ Health; 1977 Nov; 3(4):633-6. PubMed ID: 592431
    [No Abstract]   [Full Text] [Related]  

  • 36. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.
    Peto R; Pike MC; Day NE; Gray RG; Lee PN; Parish S; Peto J; Richards S; Wahrendorf J
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):311-426. PubMed ID: 6935185
    [No Abstract]   [Full Text] [Related]  

  • 37. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical carcinogenicity and the antineoplastic agents.
    Taylor AT; Wade AE
    Am J Hosp Pharm; 1984 Sep; 41(9):1844-8. PubMed ID: 6496522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of carcinogenic and in vivo genotoxic potency estimates.
    Sanner T; Dybing E
    Basic Clin Pharmacol Toxicol; 2005 Feb; 96(2):131-9. PubMed ID: 15679476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.